Activation of 5-HT2A/C Receptors Counteracts 5-HT1A Regulation of N-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Abnormal serotonin-glutamate interaction in prefrontal cortex (PFC) is implicated in the pathophysiology of many mental disorders, including schizophrenia and depression. However, the mechanisms by which this interaction occurs remain unclear. Our previous study has shown that activation of 5-HT(1A) receptors inhibits N-methyl-D-aspartate (NMDA) receptor (NMDAR) currents in PFC pyramidal neurons by disrupting microtubule-based transport of NMDARs. Here we found that activation of 5-HT(2A/C) receptors significantly attenuated the effect of 5-HT(1A) on NMDAR currents and microtubule depolymerization. The counteractive effect of 5-HT(2A/C) on 5-HT(1A) regulation of synaptic NMDAR response was also observed in PFC pyramidal neurons from intact animals treated with various 5-HT-related drugs. Moreover, 5-HT(2A/C) stimulation triggered the activation of extracellular signal-regulated kinase (ERK) in dendritic processes. Inhibition of the beta-arrestin/Src/dynamin signaling blocked 5-HT(2A/C) activation of ERK and the counteractive effect of 5-HT(2A/C) on 5-HT(1A) regulation of NMDAR currents. Immunocytochemical studies showed that 5-HT(2A/C) treatment blocked the inhibitory effect of 5-HT(1A) on surface NR2B clusters on dendrites, which was prevented by cellular knockdown of beta-arrestins. Taken together, our study suggests that serotonin, via 5-HT(1A) and 5-HT(2A/C) receptor activation, regulates NMDAR functions in PFC neurons in a counteractive manner. 5-HT(2A/C), by activating ERK via the beta-arrestin-dependent pathway, opposes the 5-HT(1A) disruption of microtubule stability and NMDAR transport. These findings provide a framework for understanding the complex interactions between serotonin and NMDARs in PFC, which could be important for cognitive and emotional control in which both systems are highly involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been found that 5-HT1A receptors in PFC pyramidal neurons suppress NMDAR function by disrupting the microtubule/kinesin-based dendritic transport of NMDA receptors 83, while this effect of 5-HT1A is opposed by 5-HT2A/C signaling 82.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Payne, D. M., Rossomando, A. J., Martino, P., Erickson, A. K., Her, J. H., Shabanowitz, J., Hunt, D. F., Weber, M. J., & Sturgill, T. W. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08021.x · Cited by 1,040
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., & Hen, R. (2002) · Nature · doi:10.1038/416396a · Cited by 903
Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B Receptor
Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Segu, L., Buhot, M.-C., & Hen, R. (1994) · Science · doi:10.1126/science.8091214 · Cited by 845
Research works printed but not linked: 1
- Gout, 1993, Cell, 75, 25, 10.1016/s0092-8674(05)80081-9 · doi:10.1016/s0092-8674(05)80081-9 · Paper page
Cited by
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
“Likewise, 5-HT modulates NMDA transmission in PFC via 5-HT1A and 5-HT2A receptors, with opposite actions of both receptors (Yuen et al., 2008; Zhong et al., 2008).”
BackgroundLesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435
“In contrast, 5-HT2A/2C activation increases NMDA receptor-mediated currents by activating the ERK1/2 pathway via the b-arrestin/Src/dynamin cascade, thus counteracting the effects of 5-HT1A activation in decreasing NMDA receptor-mediated currents (Yuen et al., 2008).”
The role of serotonin receptors in the action of atypical antipsychotic drugs
Meltzer, H., & Massey, B. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.007 · Cited by 381
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Albert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions
MILLAN, M., MARIN, P., BOCKAERT, J., & MANNOURYLACOUR, C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.007 · Cited by 320
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“It has been found that 5-HT1A receptors in PFC pyramidal neurons suppress NMDAR function by disrupting the microtubule/kinesin-based dendritic transport of NMDA receptors [83], while this effect of 5-HT1A is opposed by 5-HT2A/C signaling [82].”
BackgroundSelf-citationHallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in Pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285
Delivery of GABAARs to Synapses Is Mediated by HAP1-KIF5 and Disrupted by Mutant Huntingtin
Twelvetrees, A. E., Yuen, E. Y., Arancibia-Carcamo, I. L., MacAskill, A. F., Rostaing, P., Lumb, M. J., Humbert, S., Triller, A., Saudou, F., Yan, Z., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.007 · Cited by 276
Self-citationRaehal, K. M., Schmid, C. L., Groer, C. E., & Bohn, L. M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004598 · Cited by 256
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225
The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging
Vecchio, L. M., Meng, Y., Xhima, K., Lipsman, N., Hamani, C., & Aubert, I. (2018) · Brain Plasticity · doi:10.3233/bpl-180069 · Cited by 225
Savignac, H. M., Couch, Y., Stratford, M., Bannerman, D. M., Tzortzis, G., Anthony, D. C., & Burnet, P. W. J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.007 · Cited by 223
“The current study investigated NMDARs as potential intermediaries of the observed LPS and BGOS effects, since they interact with 5-HT2ARs (Yuen et al., 2008), mediate neurotoxicity in central inflammation (Ma et al., 2014), and are modulated by BGOS (Savignac et al., 2013).”
The 5-HT1A receptor: Signaling to behavior
Albert, P. R., & Vahid-Ansari, F. (2019) · Biochimie · doi:10.1016/j.biochi.2018.10.015 · Cited by 210
Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes
Kalueff, A. V., Olivier, J. D. A., Nonkes, L. J. P., & Homberg, J. R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.003 · Cited by 203
Alcohol and the prefrontal cortex
Abernathy, K., Chandler, L. J., & Woodward, J. J. (2010) · International Review of Neurobiology · doi:10.1016/s0074-7742(10)91009-x · Cited by 196
Newman‐Tancredi, A., & Kleven, M. S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2247-y · Cited by 174
Chatterjee, M., Verma, R., Ganguly, S., & Palit, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.041 · Cited by 162
Asan, E., Steinke, M. R., & Lesch, K. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1081-1 · Cited by 156
Selective serotonergic excitation of callosal projection neurons
Avesar, D., & Gulledge, A. T. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00012 · Cited by 124
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
Meltzer, H. Y., Horiguchi, M., & Massey, B. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2137-8 · Cited by 134
Meltzer, H. Y., Rajagopal, L., Huang, M., Oyamada, Y., Kwon, S., & Horiguchi, M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000928 · Cited by 113
Cortical Plasticity, Excitatory–Inhibitory Balance, and Sensory Perception
Carcea, I., & Froemke, R. C. (2013) · Progress in Brain Research · doi:10.1016/b978-0-444-63327-9.00003-5 · Cited by 110
“…calcium and can interact directly or indirectly with AMPA, NMDA, and metabotropic glutamate receptors, thus controlling synaptic transmission, neuron excitability, and network excitatory to inhibitory balance (Bockaert et al., 2010; Moreau et al., 2010; Ogren et al., 2008; Yuen et al., 2005, 2008).”
Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 103
Rodríguez-Muñoz, M., Sánchez‐Blázquez, P., Merlos, M., & Garzón-Niño, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10095 · Cited by 92
Snigdha, S., Horiguchi, M., Huang, M., Li, Z., Shahid, M., Neill, J. C., & Meltzer, H. Y. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156349 · Cited by 90
Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia
Doyle, G. A. R., Crist, R. C., Karatas, E. T., Hammond, M. J., Ewing, A. D., Ferraro, T. N., Hahn, C.-G., & Berrettini, W. H. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.115 · Cited by 86
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex
Nocjar, C., Alex, K. D., Sonneborn, A., Abbas, A. I., Roth, B. L., & Pehek, E. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.050 · Cited by 85
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Marinova, Z., Chuang, D.-M., & Fineberg, N. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170320104237 · Cited by 83
“Interestingly, interactions with serotonergic signalling for both ionotropic and metabotropic glutamate receptors have been demonstrated [41, 42].”
BackgroundEarly life stress as an influence on limbic epilepsy: a hypothesis whose time has come?
Koe, A. S., Jones, N. C., & Salzberg, M. R. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.024.2009 · Cited by 81
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
Ellaithy, A., Younkin, J., González‐Maeso, J., & Logothetis, D. E. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.06.002 · Cited by 80
Somato-Dendritic Regulation of Raphe Serotonin Neurons; A Key to Antidepressant Action
Quentin, E., Belmer, A., & Maroteaux, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00982 · Cited by 79
Gong, Y., & Lippa, C. F. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382893 · Cited by 76
Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
Polter, A. M., & Li, X. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00031 · Cited by 67
Marsden, W. N. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.021 · Cited by 72
Bonn, M., Schmitt, A. G., Lesch, K., Bockstaele, E. J. V., & Asan, E. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0406-5 · Cited by 71
Nietzer, S., Bonn, M., Jansen, F., Heiming, R. S., Lewejohann, L., Sachser, N., Asan, E., Lesch, K., & Schmitt, A. G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.011 · Cited by 68
Rodríguez-Muñoz, M., Cortés‐Montero, E., Pozo-Rodrigálvarez, A., Sánchez‐Blázquez, P., & Garzón-Niño, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6064 · Cited by 66
Köles, L., Kató, E., Hanuska, A., Zádori, Z., Al‐Khrasani, M., Zelles, T., Rubini, P., & Illés, P. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9480-5 · Cited by 65
Aznar, S., & Klein, A. B. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8472-0 · Cited by 64
Serotonin receptor signaling and regulation via β-arrestins
Bohn, L., & Schmid, C. L. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.516741 · Cited by 64
Millan, M. J., Marin, P., Kamal, M. T., Jockers, R., Chanrion, B., Labasque, M., Bockaert, J., & la Cour, C. M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001045 · Cited by 61
Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
Ghasemi, M., Phillips, C., Fahimi, A., McNerney, M. W., & Salehi, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.002 · Cited by 58
Lutzu, S., & Castillo, P. E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.019 · Cited by 56
Rodríguez-Muñoz, M., Sánchez-Blázquez, P., & Garzón, J. (2018) · Oncotarget · doi:10.18632/oncotarget.25169 · Cited by 47
Klein, A. B., Santini, M. A., Aznar, S., Knudsen, G. M., & Rios, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.054 · Cited by 50
Xiang, M., Jiang, Y., Hu, Z., Yang, Y., Du, X., Botchway, B. O. A., & Fang, M. (2019) · PubMed · Cited by 50
Iasevoli, F., Tomasetti, C., Ambesi‐Impiombato, A., Muscettola, G., & de Bartolomeis, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.009 · Cited by 49
Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment
Huang, X., & Song, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21512 · Cited by 47
Classification and Signaling Characteristics of 5-HT Receptors
Bockaert, J., Claeysen, S., Dumuis, A., & Marin, P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70073-4 · Cited by 47
Marin, P., Bécamel, C., Chaumont‐Dubel, S., Vandermoere, F., Bockaert, J., & Claeysen, S. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00005-0 · Cited by 46
Stephens, E. K., Avesar, D., & Gulledge, A. T. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00097 · Cited by 33
Yin, L., Rasch, M. J., He, Q., Wu, S., Dou, F., & Shu, Y. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv245 · Cited by 40
Yuen, E. Y., Li, X., Wei, J., Horiguchi, M., Meltzer, H. Y., & Yan, Z. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076141 · Cited by 38
“, 2005), whereas a 5-HT2A agonist or antagonist alone had no effect on NMDAR-EPSC (Yuen et al., 2008).”
BackgroundSelf-citationA Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 37
Raab, K., Kirsch, P., & Mier, D. U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.031 · Cited by 37
Yamada, M., Kawahara, Y., Kaneko, F., Kishikawa, Y., Sotogaku, N., Poppinga, W. J., Folgering, J. H. A., Dremencov, E., Kawahara, H., & Nishi, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.044 · Cited by 37
Bennett, A., & Maxwell, R. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903555146 · Cited by 35
Sidiropoulou, K., & Poirazi, P. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002489 · Cited by 35
Bechthold, E., Schreiber, J. A., Lehmkuhl, K., Frehland, B., Schepmann, D., Bernal, F. A., Daniliuc, C. G., Álvarez, I., Garcia, C. V., Schmidt, T. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01912 · Cited by 34
Hearing Loss Alters Serotonergic Modulation of Intrinsic Excitability in Auditory Cortex
Rao, D., Basura, G. J., Roche, J. P., Daniels, S. D., Mancilla, J. G., & Manis, P. B. (2010) · Journal of Neurophysiology · doi:10.1152/jn.01092.2009 · Cited by 33
Oyamada, Y., Horiguchi, M., Rajagopal, L., Miyauchi, M., & Meltzer, H. Y. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.040 · Cited by 33
Neuroticism and serotonin 5-HT1A receptors in healthy subjects
Hirvonen, J., Tuominen, L. J., Någren, K., & Hietala, J. A. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.04.007 · Cited by 33
Chatterjee, M., Verma, R., Kumari, R., Singh, S., Verma, A. K., Dwivedi, A. K., & Palit, G. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.976350 · Cited by 32
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Zhang, T., Liu, C., Zhong, N., Wang, Y., Huang, Y., & Zhang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910668 · Cited by 31
Wang, H., Hu, L., Liu, C., Su, Z., Wang, L., Pan, G., Guo, Y., & He, J. (2016) · Scientific Reports · doi:10.1038/srep20033 · Cited by 31
Eickelbeck, D., Karapinar, R., Jäck, A., Süß, S. T., Barzan, R., Azimi, Z., Surdin, T., Grömmke, M., Mark, M. D., Gerwert, K. B., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0292-y · Cited by 30
Serotonergic neuromodulation of synaptic plasticity
Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29
Seitz, P. K., Bremer, N. M., McGinnis, A. G., Cunningham, K. A., & Watson, C. S. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-25 · Cited by 29
Maio, R. D., Colangeli, R., & Giovanni, G. D. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00080 · Cited by 27
Wang, Y., Liu, Y., Xiong, J., Di, T., Yuan, Z., Wu, J., & Chen, L. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113030 · Cited by 25
Vargas-Pérez, H., Grieder, T. E., Ting‐A‐Kee, R. A., Maal‐Bared, G., Chwalek, M., & van der Kooy, D. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13572 · Cited by 23
Beecher, K., Wang, J., Jacques, A., Chaaya, N., Chehrehasa, F., Belmer, A., & Bartlett, S. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.678267 · Cited by 17
Liu, X., Zhang, G.-F., Dong, L., Wang, X., Sun, H.-L., Shen, J.-C., Li, W., & Xu, J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1103-3 · Cited by 22
Layer-specific serotonergic facilitation of IPSC in layer 2/3 pyramidal neurons of the visual cortex
Jang, H., Cho, K., Park, S., Kim, M.-J., Yoon, S. H., & Rhie, D. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00535.2011 · Cited by 22
Herian, M., Wojtas, A., Sobocińska, M. K., Skawski, M., González-Marín, A., & Gołembiowska, K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00181-4 · Cited by 20
Yuen, E. Y., Qin, L., Wei, J., Liu, W., Liu, A., & Yan, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567610 · Cited by 20
Self-citationElectrophysiology of 5-HT6 Receptors
Tassone, A., Madeo, G., Sciamanna, G., Pisani, A., & Bonsi, P. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-384976-2.00005-8 · Cited by 20
Yeung, L. Y., Kung, H. F., & Yew, D. T. W. (2010) · AGE · doi:10.1007/s11357-010-9152-x · Cited by 20
Abnormal 5-HT modulation of stress behaviors in the Kv4.2 knockout mouse
Lockridge, A. D., Su, J., & Yuan, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.047 · Cited by 15
Rajkumar, R., & Mahesh, R. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777256 · Cited by 15
Head movement: A novel serotonin-sensitive behavioral endpoint for tail suspension test analysis
Lockridge, A. D., Newland, B., Printen, S., Romero, G. E., & Yuan, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.032 · Cited by 14
Abreu, I. R. D., Barkdull, A. P., Munoz, J. R., Smith, R. P., & Craddock, T. J. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41600-9 · Cited by 13
Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches
Lim, D. X. E., Yeo, S. Y., Chia, Z. Y. A., Fernandis, A. Z., Lee, J., & Chua, J. J. E. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01375 · Cited by 13
Martín‐Guerrero, S. M., Alonso-Batan, P., Iglesias, A., Cimadevila, M., Brea, J. M., Loza, M. I., Casado, P., Martín‐Oliva, D., Cutillas, P. R., González‐Maeso, J., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114440 · Cited by 13
Li, Y., Xiang, K., Xu, X., Zhao, X., Li, Y., Zheng, L., & Wang, J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.013 · Cited by 13
Noradrenergic α2 receptor attenuated inflammatory pain through STEP 61/ ERK signalling
Xu, Y., Wang, X. T., Zhang, Z., Suo, Z., Yang, X. Z., & Hu, X. D. (2015) · European Journal of Pain · doi:10.1002/ejp.660 · Cited by 13
Ferreira, R., Brandão, M. L., & Nobre, M. J. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.05.017 · Cited by 13
Saitow, F., Takumi, T., & Suzuki, H. (2020) · Molecular Brain · doi:10.1186/s13041-020-00655-9 · Cited by 12
Bonn, M., Schmitt, A. G., & Asan, E. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0882-3 · Cited by 12
G-protein coupled receptors and synaptic plasticity in sleep deprivation
Parmar, S., Tadavarty, R., & Sastry, B. R. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.954 · Cited by 11
NMDA and AMPA receptor physiology and role in visceral hypersensitivity: a review
Cheng, F., Du, L., Kim, J. J., Zhu, F., He, H., & Dai, N. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002351 · Cited by 11
Villalba, S., González, B., Junge, S., Bernardi, A., González, J., Fagúndez, C., Torterolo, P., Carrera, I., Urbano, F. J., & Bisagno, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020687 · Cited by 11
Role of 5‐ HT 1A receptor in insular cortex mediating stress – induced visceral sensory dysfunction
Sun, H., Xu, S., Yi, L., Chen, Y., Wu, P., Cao, Z., Zhou, L., Jiang, Y., & Zhang, D. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12815 · Cited by 11
Bernášková, K., Tomkova, S., & Šlamberová, R. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.08.009 · Cited by 11
Vargas-Pérez, H., Grieder, T. E., & van der Kooy, D. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2033889 · Cited by 10
Luo, B., Hu, L., Liu, C., Guo, Y., & Wang, H. (2015) · Amino Acids · doi:10.1007/s00726-015-2086-y · Cited by 10
Activation of 5-HT 2A/2C receptors reduces the excitability of cultured cortical neurons
Hu, L., Liu, C., Dang, M., Luo, B., Guo, Y., & Wang, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.052 · Cited by 10
Szénási, T., Turu, G., & Hunyady, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.957981 · Cited by 9
Metadata
- Authors
- Yuen, E. Y., Jiang, Q., Chen, P., Feng, J., & Yan, Z.
- Affiliations
- University at Buffalo, State University of New York (US)
- Corresponding author
- Yan, Zhen
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 283
- Issue
- 25
- Pages
- 17194-17204
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2427346
- OpenAlex
- W2168545629
- Cited by
- 125
- References
- 53
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 8 · 2012: 9
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4495 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health (MH 63128, R01MH063128)
- National Institute of Neurological Disorders and Stroke (NS48911, R01NS048911)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A/C receptor, 5-HT1A receptor, NMDA receptor currents, microtubule depolymerization, beta-arrestin, ERK signaling, NR2B subunit, schizophrenia, depression
- MeSH terms
- Animals, Cells, Cultured, Electrophysiology, Gene Expression Regulation, Male, Neurons, Serotonin, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Pyramidal Cells, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.